RxDoctor Payments Data

Sharon Saunders

Nurse Practitioner · Candor, NCNPI 1508905480

Payments from drug & device makers

$523in general payments, 2019–2025

Across 31 payments — averaging $16.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$137
  • AstraZeneca$121
  • Lilly USA, LLC$86
  • Sanofi-aventis U.S. LLC$42
  • Shield Therapeutics Inc$35
  • Phathom Pharmaceuticals, Inc.$32
  • plus $70 from 4 others

What the payments were for

  • Food & beverage$523100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$523 in reported general payments places this provider in the 65th percentile of 4,393 nurse practitioner providers in North Carolina.

See all nurse practitioner providers in North Carolina

Medicare billing

Part B allowed, 2024
$34,782
Medicare patients
67
Services billed
601

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin47$41,073
EliquisApixaban46$29,805
OzempicSemaglutide12$22,984
EntrestoSacubitril/Valsartan12$12,962
Spiriva HandihalerTiotropium Bromide18$12,214
JanuviaSitagliptin Phosphate14$10,420
Repatha SureclickEvolocumab16$9,506
Trelegy ElliptaFluticasone/Umeclidin/Vilanter14$9,242
Insulin Lispro Kwikpen U-100Insulin Lispro18$3,885
Advair DiskusFluticasone Propion/Salmeterol11$3,416
Rosuvastatin Calcium348$3,024
Ventolin HfaAlbuterol Sulfate34$2,833
Albuterol Sulfate HfaAlbuterol Sulfate81$2,378
Ezetimibe108$2,325
Potassium Chloride149$2,291

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$13$41,07347 claims
Novo NordiskOzempic$137$22,98412 claims
NovartisEntresto$22$12,96212 claims
MerckJanuvia$18$10,42014 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 4,393 nurse practitioner providers in North Carolina.

Other nurse practitioner in Candor

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →